Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Still Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02165345
What this trial is testing

Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 82
Testing effectiveness (Phase 2)Study completedNCT05055128
What this trial is testing

A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole

Who this might be right for
Erosive Esophagitis
Cinclus Pharma Holding AB 248
Large-scale testing (Phase 3)WithdrawnNCT05432960
What this trial is testing

Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)

Who this might be right for
Adult-Onset Still's DiseaseAOSD
R-Pharm International, LLC
Not applicableLooking for participantsNCT04402086
What this trial is testing

Rheumatology Patient Registry and Biorepository

Who this might be right for
Rheumatic DiseasesAdult Onset Still DiseaseAnkylosing Spondylitis+17 more
Yale University 5,000
Not applicableLooking for participantsNCT06339177
What this trial is testing

Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study

Who this might be right for
Lymphohistiocytosis, HemophagocyticSecondary Hemophagocytic LymphohistiocytosisMacrophage Activation Syndrome+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 300
Post-approval studies (Phase 4)Study completedNCT01397084
What this trial is testing

To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

Who this might be right for
Gastroesophageal Reflux DiseaseGERDReflux Esophagitis
AstraZeneca 107
Large-scale testing (Phase 3)Ended earlyNCT00078806
What this trial is testing

Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis

Who this might be right for
Juvenile Rheumatoid Arthritis
Amgen 19
Post-approval studies (Phase 4)Not Yet RecruitingNCT03454646
What this trial is testing

Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL)

Who this might be right for
Alzheimer DiseaseCholinesterase Inhibitors
University Hospital, Bordeaux 1,205
Large-scale testing (Phase 3)UnknownNCT06463379
What this trial is testing

The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis

Who this might be right for
Refractory Juvenile Idiopathic Arthritis (Despite 2 DMARDs Still Active)
Sohag University 215
Not applicableLooking for participantsNCT02143986
What this trial is testing

Glycosylated Ferritin in Macrophagic Activation Syndromes

Who this might be right for
Still's Disease, Adult-OnsetSepsisMacrophagic Activation Syndrome
Brugmann University Hospital 60
Large-scale testing (Phase 3)Ended earlyNCT00657553
What this trial is testing

Preemptive Strike With Bortezomib in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
University of Arkansas 10
Large-scale testing (Phase 3)Study completedNCT00339157
What this trial is testing

Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS

Who this might be right for
Systemic-Onset Juvenile Idiopathic Arthritis
Institut National de la Santé Et de la Recherche Médicale, France 24
Testing effectiveness (Phase 2)Study completedNCT00152503
What this trial is testing

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

Who this might be right for
Epilepsy, Partial
UCB Pharma SA 59
Not applicableUnknownNCT06227936
What this trial is testing

Complications of Cholecystostomy in ACC

Who this might be right for
Cholecystitis
Hospital del Mar 2,000
Not applicableStudy completedNCT03514355
What this trial is testing

MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms

Who this might be right for
Rheumatoid ArthritisDepressive Symptoms
Université de Sherbrooke 39
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Testing effectiveness (Phase 2)Study completedNCT03311854
What this trial is testing

Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)

Who this might be right for
Macrophage Activation SyndromeLymphohistiocytosis, HemophagocyticArthritis, Juvenile+1 more
Swedish Orphan Biovitrum 14
Large-scale testing (Phase 3)Ended earlyNCT00886769
What this trial is testing

Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 84
Early research (Phase 1)UnknownNCT05027373
What this trial is testing

Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection

Who this might be right for
Systemic Juvenile Idiopathic ArthritisPeriodic Fever Syndrome
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 34
Post-approval studies (Phase 4)WithdrawnNCT07706868
What this trial is testing

An Efficacy and Safety Study of Subcutaneous Anakinra in Chinese Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Adult-Onset Still's Disease (AOSD)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (sJIA)Adult Onset Still's Disease (AOSD)
Swedish Orphan Biovitrum
Next Page